Revlimid

New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
Celgene Corporation to Continue Dominating Myeloma Market
Bidness, ETC
Wed, 12/30/15 - 11:14 am
Celgene
Multiple Myeloma
Revlimid
Celgene opens door for early launch of Revlimid generics
Fierce Pharma
Wed, 12/23/15 - 09:27 pm
Celgene
Revlimid
generics
Natco
4 Blockbuster Drugs Whose Sales Could Easily Double
Motley Fool
Mon, 10/26/15 - 08:46 am
Xtandi
Medivation
Astellas
Eliquis
Pfizer
Bristol-Myers Squibb
Revlimid
Celgene
Invokana
JNJ
The Best-Selling Drugs in the World By 2020
Motley Fool
Sat, 09/26/15 - 09:59 am
Harvoni
Gilead Sciences
Revlimid
Celgene
aducanumab
Biogen
op-selling drugs might be first in line for Medicare price negotiations
Fierce Pharma
Wed, 09/23/15 - 09:50 pm
Medicare
drug pricing
Hillary Clinton
GSK
Advair
AstraZeneca
Crestor
Merck
Januvia
Sanofi
Lantus
Celgene
Revlimid
4 Reasons To Keep An Eye On Top Biotech Celgene
Investors.com
Sat, 08/22/15 - 08:49 am
Celgene
Revlimid
Juno Therapeutics
Receptos
Celgene's Revlimid Patent Families Do Not Appear To Meet Criteria For Protection
Seeking Alpha
Thu, 05/14/15 - 11:01 am
Celgene
Revlimid
patents
Europe
Celgene: So Much For That Patent Hearing
Barron's
Thu, 05/7/15 - 10:57 am
Celgene
patents
Revlimid
Celgene: Just How Worrisome is Its European Patent Hearing?
Barron's
Fri, 05/1/15 - 04:26 pm
Celgene
patents
Europe
Revlimid
When Will Celgene's Key Patents Expire?
Investopedia
Thu, 04/2/15 - 10:02 am
patents
Celgene
Revlimid
Abraxane
Pomolyst
What leads the herd of pharma's biggest cash cows? It's not what you think
Fierce Pharma
Wed, 03/4/15 - 07:01 pm
Celgene
Revlimid
Gilead Sciences
Sovaldi
Humira
AbbVie
Celgene's Approval Means That Sales Could Surge
Investopedia
Fri, 02/27/15 - 10:05 am
Celgene
Multiple Myeloma
Revlimid
Is Revlimid Becoming a Catch-All Cancer Drug?
24/7 Wall St
Thu, 02/19/15 - 07:54 am
Revlimid
Celgene
Multiple Myeloma
cancer
U.S. FDA approves new use for Celgene's cancer drug Revlimid
Yahoo/Reuters
Wed, 02/18/15 - 04:18 pm
FDA
Celgene
Revlimid
Multiple Myeloma
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Mon, 02/16/15 - 12:00 pm
FDA
Celgene
Revlimid
Multiple Myeloma
Regeneron
Eylea
Vertex Pharmaceuticals
Kalydeco
lumacaftor
Celgene: European Decision Not Best Case Scenario, Not Worst Case Either
Barron's
Fri, 12/19/14 - 04:03 pm
Celgene
Europe
Revlimid
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
Data on Celgene's Revlimid Published in Oncology Journal
Yahoo/Zacks
Sat, 08/23/14 - 09:52 am
Celgene
Revlimid
diffuse large B-cell lymphoma
lymphoma
Gilead Sciences and Celgene Corporation Have Great Growth Potential
Motley Fool
Tue, 07/1/14 - 10:31 am
Celgene
Gilead Sciences
Revlimid
Sovaldi

Pages